[1]
“ The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model ”, Clinics, vol. 66, no. 8, pp. 1443–1450, Jan. 2011, doi: 10.1590/S1807-59322011000800023.